On the HCPLive Atopic Dermatitis condition center page, audiences can find a variety of coverage mediums for medical news and updates, including articles, video interviews, podcasts, and breaking news on dermatitis research, treatment, and drug development.
October 26th 2024
In these data presented at the Fall Clinical Dermatology conference, population-based data on utilization and duration of systemic corticosteroid exposure was highlighted.
'Understand AD' Raises Awareness for Atopic Dermatitis Patients
From childhood to adulthood atopic dermatitis is a condition that can have an extremely negative impact on a person's life. Knowing the best way to manage the symptoms can go a long way in improving quality of life issues.
Predicting and Preventing Atopic Dermatitis in Children
November 6th 2015Atopic dermatitis, sometimes referred to as baby eczema, affects more than three million infants in the United States every year. While there are no established preventive measures, researchers have been making strides in coming up with effective treatment strategies.
What Are the Most Unnecessary and Overused Procedures in Dermatology?
The American Academy of Dermatology (AAD) recently released new recommendations encouraging physicians to thoroughly inform patients of their options when it comes to dermatologic medications and procedures.
Children with Asthma and Eczema More Likely to Be Bullied at School
As summer comes to a close and many have already sent their children off to a new year of school, a study in PLOS One suggests that children who have asthma or eczema may face significant challenges fitting in with their peers.
Bathing in the Dead Sea, and Other Alternative Therapies for Atopic Dermatitis
A review article recently examined the evidence (or lack thereof) supporting the use of textiles, vitamin supplements, climatotherapy, probiotics, bleach baths, and other forms of complementary and alternative medicine for the treatment of atopic dermatitis.
Researchers Develop Effective New Atopic Dermatitis Skin Cream
Anacor Pharmaceuticals recently announced favorable results from two phase 3 pivotal studies for Crisaborole Topical Ointment, 2% (previously AN2728), a non-steroidal topical anti-inflammatory PDE-4 inhibitor for treating children and adults suffering from mild-to-moderate atopic dermatitis.
What Role Does a Patient's Personality Play in Dermatologic Conditions?
Researchers have shown there is a connection between personality characteristics and certain dermatological conditions, most notably in psoriasis and atopic dermatitis. Incorporating the information into your practice involves being at least somewhat aware of psychological factors that may contribute to these conditions.
Education Needs Are High for Atopic Dermatitis Patients
One of the lead characters in the HBO smash hit Game of Thrones has been told by several characters: "You know nothing, Jon Snow." Unfortunately, a similar quote could be used to describe patients with atopic dermatitis (AD). At the very least, the quote could be modified to, "You know very little."
FDA Grants Dupilumab Breakthrough Therapy Designation in Atopic Dermatitis
Regeneron Pharmaceuticals, Inc. and Sanofi recently announced the US food and Drug Administration (FDA) granted Breakthrough Therapy designation to dupilumab, a fully-human monoclonal antibody, to treat adults suffering from moderate to severe atopic dermatitis (AD)who had an insufficient response to or who were not suitable for topical prescription therapy.